GAITHERSBURG, Md., Aug. 5, 2015 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), today announced that financial results for the company's second quarter ended June 30, 2015 will be released Thursday, August 13, 2015 following the close of market. The management team will host a conference call discussing the company's financial results and recent developments on Thursday, August 13, 2015 at 4:30 p.m. E.T. The call may be accessed by dialing (888) 883-4599 (domestic) or (484) 653-6821 (international) five minutes prior to the start of the call and providing passcode 99480546.
The live, listen-only webcast of the conference call may be accessed by visiting the investors section of the company's website at http://ir.opgen.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website.
A telephone replay also will be available from 8:00 p.m. E.T. through August 19, 2015 and may be accessed by dialing (855) 859-2056 from within the U.S. or (404) 537-3406 from outside the U.S. All listeners should provide passcode 99480546.
OpGen, Inc. is an early commercial-stage company using molecular testing and bioinformatics to assist healthcare providers in combating multi-drug resistant bacterial infections. The company's products and services are designed to enable the rapid identification of hospital patients who are colonized or infected with life-threatening MDROs. The company's products include the Acuitas MDRO Gene Test, CR Elite Test, Resistome Test, Whole Genome Sequence Analysis and the Acuitas Lighthouse MDRO Management System. In addition, the company has more than 10 years of experience mapping microbial, plant and human genomes. Learn more at www.opgen.com.
CONTACT: OpGenMichael Farmer
Kim Sutton Golodetz